Send us Feedback

Acorda Therapeutics (ACOR)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ACOR » Topics » Net Cash Provided by Financing

This excerpt taken from the ACOR 10-Q filed May 11, 2009.

Net Cash Provided by Financing

        Net cash provided by financing activities for the three-month period ended March 31, 2009 was $694,000 due to $952,000 in proceeds from option exercises which was offset by $258,000 in repayments to PRF.

These excerpts taken from the ACOR 10-K filed Mar 2, 2009.

Net Cash Provided by Financing

        Net cash provided by financing activities for the year ended December 31, 2008 was $203.2 million, primarily due to $205.1 million in net proceeds from the issuance of common stock and exercise of stock options which was partially offset by $1.6 million in repayments to PRF and $188,000 for notes payable.

Net Cash Provided by Financing



        Net cash provided by financing activities for the year ended December 31, 2008 was $203.2 million, primarily due to
$205.1 million in net proceeds from the issuance of common stock and exercise of stock options which was partially offset by $1.6 million in repayments to PRF and $188,000 for notes
payable.



This excerpt taken from the ACOR 10-Q filed Nov 10, 2008.

Net Cash Provided by Financing

        Net cash provided by financing activities for the nine-month period ended September 30, 2008 was $203.0 million, primarily due to $204.7 million in net proceeds from the issuance of common stock and option exercises, which was partially offset by $1.5 million in repayments to PRF and $188,000 for notes payable.

EXCERPTS ON THIS PAGE:

10-Q
May 11, 2009
10-K (2 sections)
Mar 2, 2009
10-Q
Nov 10, 2008

RELATED TOPICS for ACOR:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki